Furthermore, it was reported that polymorphisms in the soluble epoxide hydrolysis (sEH) gene that lead to higher soluble epoxide hydrolysis (sEH) activity were associated with cardiovascular diseases [59,60]. The gene discussed is EPHX2; the disease is cardiovascular disorder.